Author:
Liu Zi-yi,Kan Xue-feng,Zhang Li-jie,Makamure Joyman,Li Qing,Zhao Dan,Zhou Guo-feng,Feng Gan-sheng,Zheng Chuan-sheng,Liang Bin
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet, 2018,391(10127):1301–1314
2. Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int, 2015,35(9):2155, 2166
3. Bargellini I, Florio F, Golfieri R, et al. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology. Cardiovasc Intervent Radiol, 2017,37(4):438–444
4. Gaba, RC, Lokken RP, Hickey RM, et al. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. J Vasc Interv Radiol, 2017,28(9):1210–1223.e3
5. Liang B, Zheng CS, Feng GS, et al. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. Cardiovasc Intervent Radiol, 2010,33(4):806–812
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献